{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:47:53Z","timestamp":1793821673666,"version":"4.6.1"},"reference-count":82,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T00:00:00Z","timestamp":1736121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Hypertension is a major risk factor of various cardiac complications, including hypertensive heart disease (HHD). This condition can lead to a number of structural and functional changes in the heart, such as left ventricular hypertrophy, diastolic dysfunction, and, eventually, systolic dysfunction. In the management of hypertensive heart disease, early diagnosis and appropriate treatment are crucial for preventing the progression to congestive heart failure. One potential diagnostic marker that has gained attention in recent years is the N-terminal pro-brain natriuretic peptide (NT-proBNP). The natriuretic peptides, including the brain natriuretic peptide (BNP) and its inactive N-terminal fragment, are secreted by the myocardium in response to increased wall stress and volume overload. In patients with hypertensive heart disease, increased NT-proBNP levels may reflect the structural and functional changes occurring in the myocardium as a result of chronic pressure overload. Several studies have investigated the diagnostic utility of NT-proBNP in hypertensive heart disease. NT-proBNP levels can be a useful adjunct in the diagnosis of hypertensive heart disease, particularly in the assessment of diastolic dysfunction and left ventricular hypertrophy. This review paper explores the role of NT-proBNP levels in the diagnosis of hypertensive heart disease.<\/jats:p>","DOI":"10.3390\/diagnostics15010113","type":"journal-article","created":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T06:43:04Z","timestamp":1736145784000},"page":"113","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["The Role of NT-proBNP Levels in the Diagnosis of Hypertensive Heart Disease"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6687-5075","authenticated-orcid":false,"given":"Angeliki","family":"Mouzarou","sequence":"first","affiliation":[{"name":"Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-0102-5116","authenticated-orcid":false,"given":"Nikoleta","family":"Hadjigeorgiou","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despo","family":"Melanarkiti","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora Eleni","family":"Plakomyti","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Paphos General Hospital, State Health Organization Services, Paphos 8026, Cyprus"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1055\/s-0042-117368","article-title":"Einsatzgebiete und praktischer Nutzen der kardialen Marker BNP und NT-proBNP","volume":"142","author":"Luchner","year":"2017","journal-title":"DMW-Dtsch. Med. Wochenschr."},{"key":"ref_2","first-page":"S44","article-title":"NT-proBNP is superior to BNP in the detection of left ventricular systolic dysfunction in the community","volume":"4","author":"Redfield","year":"2004","journal-title":"J. Card. Fail."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"183","DOI":"10.11613\/BM.2008.018","article-title":"Diagnostic value of BNP in diastolic heart failure","volume":"18","author":"Eroglu","year":"2008","journal-title":"Biochem. Med."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40266-013-0145-1","article-title":"Managing therapeutic competition in patients with heart failure, lower urinary tract symptoms and incontinence","volume":"31","author":"Tannenbaum","year":"2014","journal-title":"Drugs Aging"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.pcad.2006.02.001","article-title":"From left ventricular hypertrophy to congestive heart failure: Management of hypertensive heart disease","volume":"48","author":"Gradman","year":"2006","journal-title":"Prog. Cardiovasc. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Nemtsova, V., Vischer, A.S., and Burkard, T. (2023). Hypertensive heart disease: A narrative review series\u2014Part 1: Pathophysiology and microstructural changes. J. Clin. Med., 12.","DOI":"10.3390\/jcm12072606"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5494\/wjh.v5.i2.41","article-title":"Hypertensive cardiomyopathy: A clinical approach and literature review","volume":"5","author":"Kuroda","year":"2015","journal-title":"World J. Hypertens."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/ncpcardio0158","article-title":"Mechanisms of disease: Pathologic structural remodeling is more than adaptive hypertrophy in hypertensive heart disease","volume":"2","author":"Querejeta","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jacc.2015.04.026","article-title":"Circulating biomarkers of myocardial fibrosis: The need for a reappraisal","volume":"65","author":"Ravassa","year":"2015","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11906-020-1017-9","article-title":"Pathophysiology of hypertensive heart disease: Beyond left ventricular hypertrophy","volume":"22","author":"Nwabuo","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Nemtsova, V., Burkard, T., and Vischer, A.S. (2023). Hypertensive Heart Disease: A Narrative Review Series\u2014Part 2: Macrostructural and Functional Abnormalities. J. Clin. Med., 12.","DOI":"10.3390\/jcm12175723"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.CIR.0000081775.72651.B6","article-title":"Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy","volume":"108","author":"Schlaich","year":"2003","journal-title":"Circulation"},{"key":"ref_13","unstructured":"Tackling, G., and Borhade, M.B. (2023). Hypertensive heart disease. StatPearls [Internet], StatPearls Publishing."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","article-title":"The progression of hypertensive heart disease","volume":"123","author":"Drazner","year":"2011","journal-title":"Circulation"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0002-9149(01)01807-0","article-title":"Impact of coronary artery disease on left ventricular systolic function and geometry in hypertensive patients with left ventricular hypertrophy (the LIFE study)","volume":"88","author":"Zabalgoitia","year":"2001","journal-title":"Am. J. Cardiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.CIR.103.1.102","article-title":"Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study","volume":"103","author":"Palmieri","year":"2001","journal-title":"Circulation"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/0735-1097(94)90145-7","article-title":"Importance of obesity, race and age to the cardiac structural and functional effects of hypertension","volume":"24","author":"Gottdiener","year":"1994","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_18","first-page":"e146","article-title":"Heart disease and stroke statistics\u20132017 update","volume":"135","author":"Update","year":"2017","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"A8","DOI":"10.1253\/circj.CJ-07-1067","article-title":"Diagnosis and treatment of myocardial fibrosis in hypertensive heart disease","volume":"72","year":"2008","journal-title":"Circ. J."},{"key":"ref_20","first-page":"1135","article-title":"The global epidemiology of heart failure","volume":"88","author":"Young","year":"2004","journal-title":"Med. Clin."},{"key":"ref_21","first-page":"237","article-title":"The causes, consequences, and treatment of left or right heart failure","volume":"7","year":"2011","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Inamdar, A.A., and Inamdar, A.C. (2016). Heart failure: Diagnosis, management and utilization. J. Clin. Med., 5.","DOI":"10.3390\/jcm5070062"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Liu, Y., Luo, X., Jia, H., and Yu, B. (2022). The effect of blood pressure variability on coronary atherosclerosis plaques. Front. Cardiovasc. Med., 9.","DOI":"10.3389\/fcvm.2022.803810"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"e004152","DOI":"10.1161\/JAHA.116.004152","article-title":"Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the Campania Salute Network)","volume":"6","author":"Izzo","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"ref_25","first-page":"505","article-title":"Regression of left ventricular hypertrophy and cardiovascular risk changes in hypertensive patients","volume":"5","author":"Verdecchia","year":"2004","journal-title":"Ital. Heart J."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/ajh.2008.2","article-title":"Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension","volume":"21","author":"Pierdomenico","year":"2008","journal-title":"Am. J. Hypertens."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ehf2.14149","article-title":"Risk factors for pre-heart failure or symptomatic heart failure based on NT-proBNP","volume":"10","author":"Aoki","year":"2023","journal-title":"ESC Heart Fail."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.ejheart.2003.12.015","article-title":"Essential biochemistry and physiology of (NT-pro) BNP","volume":"6","author":"Hall","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"411","DOI":"10.2147\/VHRM.S5789","article-title":"Natriuretic peptides (BNP and NT-proBNP): Measurement and relevance in heart failure","volume":"6","author":"Palazzuoli","year":"2010","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_31","first-page":"w02095","article-title":"B-type natriuretic peptide and obesity in heart failure: A mysterious but important association in clinical practice","volume":"23","author":"Reinmann","year":"2020","journal-title":"Cardiovasc. Med."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.clinbiochem.2005.10.011","article-title":"Assessment of BNP and NT-proBNP in emergency department patients presenting with suspected acute coronary syndromes","volume":"39","author":"Cameron","year":"2006","journal-title":"Clin. Biochem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S1071-9164(00)90015-0","article-title":"Plasma amino-terminal pro-brain natriuretic peptide: A novel approach to the diagnosis of cardiac dysfunction","volume":"6","author":"Campbell","year":"2000","journal-title":"J. Card. Fail."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ejheart.2003.12.012","article-title":"Use of NT-proBNP in routine testing and comparison to BNP","volume":"6","author":"Pfister","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.jacc.2011.05.011","article-title":"A genetic variant of the atrial natriuretic peptide gene is associated with cardiometabolic protection in the general community","volume":"58","author":"Cannone","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ejheart.2004.01.003","article-title":"NT-proBNP in heart failure: Therapy decisions and monitoring","volume":"6","author":"Richards","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3329\/cmoshmcj.v13i2.21079","article-title":"Prognostic significance of B type natriuretic peptide in acute coronary syndrome","volume":"13","author":"Chowdhury","year":"2014","journal-title":"Chattagram Maa-O-Shishu Hosp. Med. Coll. J."},{"key":"ref_38","first-page":"660","article-title":"N-terminal pro-brain natriuretics peptide as a predictor of short term outcome in acute segment elevation myocardial infarction","volume":"13","author":"Munnoli","year":"2023","journal-title":"Eur. J. Cardiovasc. Med."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.ejheart.2004.01.001","article-title":"N-terminal pro brain natriuretic peptide in arterial hypertension\u2014A marker for left ventricular dimensions and prognosis","volume":"6","author":"Hildebrandt","year":"2004","journal-title":"Eur. J. Heart Fail."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1093\/ajh\/hpad065","article-title":"Prevalence of elevated NT-proBNP and its prognostic value by blood pressure treatment and control","volume":"36","author":"Daya","year":"2023","journal-title":"Am. J. Hypertens."},{"key":"ref_41","first-page":"12","article-title":"Serum brain natriuretic peptide (BNP) and N-terminal brain natriuretic peptide (NT-proBNP) in heart valve disease","volume":"5","author":"Moolman","year":"2008","journal-title":"SA Heart"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"101132","DOI":"10.1016\/j.ijcha.2022.101132","article-title":"Atrial Fibrillation, thromboembolic risk, and the potential role of the natriuretic peptides, a focus on BNP and NT-proBNP\u2013A narrative review","volume":"43","author":"Kerr","year":"2022","journal-title":"IJC Heart Vasc."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/clc.23760","article-title":"NT Pro-BNP can be used as a risk predictor of clinical atrial fibrillation with or without left atrial enlargement","volume":"45","author":"Zhao","year":"2022","journal-title":"Clin. Cardiol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1515\/ijdhd-2015-0021","article-title":"Role of B-type natriuretic peptide (BNP) in heart failure","volume":"16","author":"Uddin","year":"2017","journal-title":"Int. J. Disabil. Hum. Dev."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cardfail.2009.10.020","article-title":"Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels","volume":"16","author":"Daniels","year":"2010","journal-title":"J. Card. Fail."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1002\/ehf2.14019","article-title":"Higher BNP\/NT-Pro BNP levels stratify prognosis equally well in patients with and without heart failure: A Meta-Analysis","volume":"9","author":"Hendricks","year":"2022","journal-title":"ESC Heart Fail."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/ncpcardio0156","article-title":"The prognostic value of N-terminal proB-type natriuretic peptide","volume":"2","author":"Burnett","year":"2005","journal-title":"Nat. Clin. Pract. Cardiovasc. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"807861","DOI":"10.1155\/2015\/807861","article-title":"Clinical applications of natriuretic peptides in assessment of valvular heart disease","volume":"2015","author":"Sharma","year":"2015","journal-title":"Dis. Markers"},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Lind, L., Loader, J., Lindahl, B., Eggers, K.M., and Sundstr\u00f6m, J. (2022). A comparison of echocardiographic and circulating cardiac biomarkers for predicting incident cardiovascular disease. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0271835"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.jacc.2020.11.063","article-title":"Association of NT-ProBNP, blood pressure, and cardiovascular events: The ARIC study","volume":"77","author":"Hussain","year":"2021","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/ejhf.3036","article-title":"Practical algorithms for early diagnosis of heart failure and heart stress using NT-proBNP: A clinical consensus statement from the Heart Failure Association of the ESC","volume":"25","author":"Docherty","year":"2023","journal-title":"Eur. J. Heart Fail."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0002-9149(02)02464-5","article-title":"Impact of age and sex on plasma natriuretic peptide levels in healthy adults","volume":"90","author":"Wang","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/j.ajem.2017.05.048","article-title":"Anemia considerations when assessing natriuretic peptide levels in ED patients","volume":"35","author":"Karakoyun","year":"2017","journal-title":"Am. J. Emerg. Med."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Gembillo, G., Visconti, L., Giusti, M.A., Siligato, R., Gallo, A., Santoro, D., and Mattina, A. (2021). Cardiorenal syndrome: New pathways and novel biomarkers. Biomolecules, 11.","DOI":"10.3390\/biom11111581"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.ijcard.2014.08.007","article-title":"Obesity and natriuretic peptides, BNP and NT-proBNP: Mechanisms and diagnostic implications for heart failure","volume":"176","author":"Madamanchi","year":"2014","journal-title":"Int. J. Cardiol."},{"key":"ref_57","doi-asserted-by":"crossref","unstructured":"Wachter, R., Lahno, R., Haase, B., Weber-Kr\u00fcger, M., Seegers, J., Edelmann, F., Wohlfahrt, J., Gelbrich, G., G\u00f6rlitz, A., and Kermer, P. (2012). Natriuretic peptides for the detection of paroxysmal atrial fibrillation in patients with cerebral ischemia\u2013the Find-AF study. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0034351"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"696.e1","DOI":"10.1016\/j.jcrc.2014.03.022","article-title":"Predictive value of plasma brain natriuretic peptide for postoperative cardiac complications\u2014A systemic review and meta-analysis","volume":"29","author":"Young","year":"2014","journal-title":"J. Crit. Care"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"S4282","DOI":"10.21037\/jtd.2018.08.15","article-title":"Biomarkers for the detection of apparent and subclinical cancer therapy-related cardiotoxicity","volume":"10","author":"Michel","year":"2018","journal-title":"J. Thorac. Dis."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Okamoto, R., Ali, Y., Hashizume, R., Suzuki, N., and Ito, M. (2019). BNP as a major player in the heart-kidney connection. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20143581"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/cclm-2022-1194","article-title":"Diagnostic utility of total NT-proBNP testing by immunoassay based on antibodies targeting glycosylation-free regions of NT-proBNP","volume":"61","author":"Li","year":"2023","journal-title":"Clin. Chem. Lab. Med."},{"key":"ref_62","first-page":"231","article-title":"Validation of a novel point-of-care testing device designed for assessment of NT-pro BNP","volume":"7","author":"Larsson","year":"2023","journal-title":"J. Fam. Med. Prim. Care Open Access"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"100748","DOI":"10.1016\/j.ijoes.2024.100748","article-title":"Advances in Electrochemical Detection of B-type Natriuretic Peptide as a Heart Failure Biomarker","volume":"19","author":"Li","year":"2024","journal-title":"Int. J. Electrochem. Sci."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.clinbiochem.2014.11.002","article-title":"Evidence based application of BNP\/NT-proBNP testing in heart failure","volume":"48","author":"McKelvie","year":"2015","journal-title":"Clin. Biochem."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"e031796","DOI":"10.1161\/JAHA.123.031796","article-title":"Correlates of Plasma NT-proBNP\/Cyclic GMP Ratio in Heart Failure With Preserved Ejection Fraction: An Analysis of the RELAX Trial","volume":"13","author":"Chiu","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Dietl, A., Stark, K., Zimmermann, M.E., Meisinger, C., Schunkert, H., Birner, C., Maier, L.S., Peters, A., Heid, I.M., and Luchner, A. (2016). NT-proBNP predicts cardiovascular death in the general population independent of left ventricular mass and function: Insights from a large population-based study with long-term follow-up. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0164060"},{"key":"ref_67","first-page":"27","article-title":"Exercise-Induced NT-pro BNP Secretion in Hypertensive Patients Without Heart Failure Can Diagnose the Subclinical Left Ventricle Dysfunction","volume":"18","author":"Sinelli","year":"2021","journal-title":"Intern. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/S0002-9149(02)02864-3","article-title":"Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden","volume":"90","author":"Tsang","year":"2002","journal-title":"Am. J. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/HJH.0000000000003615","article-title":"Left atrial mechanics evaluated by two-dimensional strain analysis: Alterations in essential hypertension","volume":"42","author":"Stefani","year":"2024","journal-title":"J. Hypertens."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijcard.2020.04.044","article-title":"Prognostic value of NT-proBNP, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction","volume":"317","author":"Blanco","year":"2020","journal-title":"Int. J. Cardiol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/ajh\/hpab018","article-title":"Association of longitudinal changes in NT-proBNP with changes in left atrial volume and function: MESA","volume":"34","author":"Varadarajan","year":"2021","journal-title":"Am. J. Hypertens."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/j.1540-8175.2008.00717.x","article-title":"The correlation of left atrial volume index to the level of N-terminal pro-BNP in heart failure with a preserved ejection fraction","volume":"25","author":"Kim","year":"2008","journal-title":"Echocardiography"},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Kadoglou, N.P., Mouzarou, A., Hadjigeorgiou, N., Korakianitis, I., and Myrianthefs, M.M. (2024). Challenges in Echocardiography for the Diagnosis and Prognosis of Non-Ischemic Hypertensive Heart Disease. J. Clin. Med., 13.","DOI":"10.20944\/preprints202403.0531.v1"},{"key":"ref_74","first-page":"66","article-title":"Is There A Correlation Between Left Atrium Diameter and NT-ProBNP Levels in Resistant Hypertension?","volume":"7","year":"2019","journal-title":"E J. Cardiovasc. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12947-022-00297-y","article-title":"Reduced left atrial contractile strain with speckle tracking analysis predicts abnormal plasma NTproBNP in an asymptomatic community population","volume":"20","author":"Liu","year":"2022","journal-title":"Cardiovasc. Ultrasound"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Li, H., Wang, H., Wang, T., Jin, C., Lu, M., and Liu, B. (2023). Different phenotype of left atrial function impairment in patients with hypertrophic cardiomyopathy and hypertension: Comparison of healthy controls. Front. Cardiovasc. Med., 10.","DOI":"10.3389\/fcvm.2023.1027665"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1093\/ejechocard\/jer283","article-title":"Relation of left ventricular end-diastolic pressure and N-terminal pro-brain natriuretic peptide level with left atrial deformation parameters","volume":"13","author":"Kurt","year":"2012","journal-title":"Eur. Heart J.\u2013Cardiovasc. Imaging"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1007\/s10554-023-02828-8","article-title":"The effect of urgent blood pressure reduction on left atrial strain in patients with hypertensive attack: Blood pressure lowering affects LA strain","volume":"39","author":"Asarcikli","year":"2023","journal-title":"Int. J. Cardiovasc. Imaging"},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1157\/13125520","article-title":"Usefulness of NT-proBNP level for diagnosing left ventricular hypertrophy in hypertensive patients. A cardiac magnetic resonance study","volume":"61","author":"Morillas","year":"2008","journal-title":"Rev. Esp. Cardiol. (Engl. Ed.)"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Chrysohoou, C., Konstantinou, K., and Tsioufis, K. (2024). The Role of NT-proBNP Levels in the Diagnosis and Treatment of Heart Failure with Preserved Ejection Fraction\u2014It Is Not Always a Hide-and-Seek Game. J. Cardiovasc. Dev. Dis., 11.","DOI":"10.20944\/preprints202406.0270.v1"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1373\/clinchem.2009.129742","article-title":"Impact of increased body mass index on accuracy of B-type natriuretic peptide (BNP) and N-terminal proBNP for diagnosis of decompensated heart failure and prediction of all-cause mortality","volume":"56","author":"Christenson","year":"2010","journal-title":"Clin. Chem."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijcard.2022.06.055","article-title":"Impact of NT-proBNP on prognosis of acute decompensated chronic heart failure versus de novo heart failure","volume":"363","author":"Kim","year":"2022","journal-title":"Int. J. Cardiol."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/1\/113\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T10:23:37Z","timestamp":1759919017000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/1\/113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,6]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,1]]}},"alternative-id":["diagnostics15010113"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15010113","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,6]]}}}